Vitreous Inflammation Associated with Intravitreal Anti-VEGF Pharmacotherapy

Vascular endothelial growth factor (VEGF) is a potent promoter of angiogenesis involved in a wide variety of physiologic processes. Intravitreal injections targeting VEGF have transformed the treatment of neovascular retinal diseases. Currently, there are four anti-VEGF agents in use: bevacizumab, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Shivi, Joshi, Malav, Christoforidis, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836427/
https://www.ncbi.nlm.nih.gov/pubmed/24307762
http://dx.doi.org/10.1155/2013/943409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836427/
https://www.ncbi.nlm.nih.gov/pubmed/24307762
http://dx.doi.org/10.1155/2013/943409

Ejemplares similares